Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Pharmacoeconomics|November 3, 1996
The economic potential of dual individualisation methodologiesJ A Paladino, G S Zimmer, J J SchentagClinical Pharmacokinetics|February 1, 1995
The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agentsJ M Hyatt, P S McKinnon, G S Zimmer, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection controlJ J Schentag, J M Hyatt, J R Carr, et al.Seminars in Respiratory Infections|January 22, 1998
In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistanceJ J Schentag, M C Birmingham, J A Paladino, et al.Kidney International|April 12, 2000
Relationship between nutritional status and the glomerular filtration rate: results from the MDRD studyJ D Kopple, T Greene, W C Chumlea, et al.Kidney International|September 18, 1997
Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease StudyJ D Kopple, A S Levey, T Greene, et al.Pageof 1